ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Integration of Lipidomics and Transcriptomics Reveals the Efficacy and Mechanism of Qige Decoction on NAFLD

Fan, Simin; Zhou, Zunming; Ye, Jintong; Li, Yanfang; Huang, Keer*; Ke, Xuehong*广州中医药大学; 1
Evidence-based Complementary and Alternative Medicine2022-11-21DOI: 10.1155/2022/9739032
1被引19阅读
引用收藏
分享

摘要

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing as obesity and diabetes become more common. There are no drugs approved for NAFLD yet. Qige decoction (QGD), a traditional Chinese medicine (TCM) formula, is used for NAFLD and hyperlipidemia treatment in TCM and has shown hypolipidemic and hepatoprotective effects. This study tried to interpret the pharmacology and molecular mechanisms of QGD in NAFLD rats. Firstly, the therapeutic effects of QGD on high-fat diet (HFD)-induced NAFLD rats were evaluated. Then, integration of lipidomics and transcriptomics was conducted to explore the possible pathways and targets of QGD against NAFLD. QGD at low dosage (QGL) administration reduced serum total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) (P < 0.05). Liver histopathology indicated that QGL could alleviate hepatic steatosis. The main differential lipids (DELs) affected by QGD were glycerolipids. KEGG enrichment analysis suggested that the main pathways by which QGD improved NAFLD may be cholesterol metabolism, glycerolipid metabolism, and insulin resistance. Transcriptome sequencing identified 179 upregulated and 194 downregulated mRNAs after QGD treatment. An interaction network based on DELs and differential genes (DEGs) suggested that QGD inhibited hepatic steatosis mainly by reducing hepatic insulin resistance and triglyceride biosynthesis via the PPP1R3C/SIK1/CRTC2 and PPP1R3C/SIK1/SREBP1 signal axis, respectively. These findings indicated that QGD could protect against NAFLD induced by HFD. The improvement of hepatic insulin resistance and the reduction of triglyceride biosynthesis might be the potential mechanisms.

学科与关键词

关键词
FATTY LIVER-DISEASEHEPATIC INSULIN-RESISTANCEELEMENT-BINDING PROTEINCREB COACTIVATOR TORC2DE-NOVO LIPOGENESISNONALCOHOLIC STEATOHEPATITISOBETICHOLIC ACIDSTEATOSISGLYCOGENEPIDEMIOLOGY
相关
加载中…
  • In silico and in vivo demonstration of the regulatory mechanism of Qi-Ge decoction in treating NAFLD
    Peng, Chong; Li, Jing; Ke, Xuehong; Liu, Fengbin*; Huang, Ke-er*Annals of Medicine, 2023, 55(1): 2200258.被引 1
  • Combining lipidomics and efficacy-oriented compatibility revealed that Qi Ge decoction compatibility improved lipid metabolism in hyperlipidemic rats
    Fan, Simin; Yu, Xiaoqing; Li, Yanfang; Zhou, Zunming; Ye, Jintong; Guo, Kaixin; Huang, Keer*; Ke, Xuehong*Biomedical Chromatography, 2023, 37(5).
  • Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
    Ding, Xin; He, Xu; Tang, Bulang; Lan, Tian*Chinese Medicine, 2024, 19(1): 21.
查看全部 →

发表信息

论文状态
公开发表
期刊
Evidence-based Complementary and Alternative Medicine
发表日期
2022-11-21
卷期
第 2022 卷
页码
9739032
DOI
10.1155/2022/9739032
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Guangzhou Municipal Science and Technology Bureau; Guangzhou University of Chinese Medicine; [82074099]; [202102010476]; [2021xk33]

作者

  • F

    Fan, Simin (第一作者)

    guangzhou univ chinese med · 1

  • Z

    Zhou, Zunming

    1 · guangzhou univ chinese med

查看全部 6 位作者收起作者
  • Y

    Ye, Jintong

    guangzhou univ chinese med · 1

  • L

    Li, Yanfang

    guangzhou univ chinese med · 1

  • H

    Huang, Keer (通讯)

    1 · guangzhou univ chinese med

  • K

    Ke, Xuehong (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417